Series D - CG Oncology - 2020-12-10 - Crunchbase

CG Oncology raised $47000000 on 2020-12-10 in Series D. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. Resources. Log In. Funding …

CouponFollow Extension

$47000000
OFF

Series D - CG Oncology - 2020-12-10 - Crunchbase

20 hours ago

CG Oncology raised $47000000 on 2020-12-10 in Series D. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. Resources. Log In. Funding …

crunchbase.com

$47
OFF

CG Oncology Closes $47 Million Series D Financing

20 hours ago

IRVINE, Calif., December 10, 2020 – CG Oncology, Inc., a clinical-stage biopharmaceutical company focused on the development of novel oncolytic immunotherapies, today announced …

cgoncology.com

$47
OFF

CG Oncology Closes $47 Million Series D Financing - BioSpace

20 hours ago

Dec 10, 2020 · CG Oncology, Inc., a clinical-stage biopharmaceutical company focused on the development of novel oncolytic immunotherapies, today announced the closing of a $47 …

biospace.com

$47
OFF

CG Oncology Closes $47 Million Series D Financing - 2020-12-10 ...

20 hours ago

Dec 10, 2020 · CG Oncology, Inc., a clinical-stage biopharmaceutical company focused on the development of novel oncolytic immunotherapies, today announced the closing of a $47 …

marketscreener.com

$47
OFF

CG Oncology Closes $47M Series D Funding - Vcnewsdaily.com

20 hours ago

CG Oncology, a clinical-stage biopharmaceutical company focused on the development of novel oncolytic immunotherapies, announced the closing of a $47 million Series D preferred stock …

vcnewsdaily.com

$100
OFF

CG Oncology - Funding, Financials, Valuation & Investors

20 hours ago

CG Oncology is funded by 21 investors. Foresite Capital and TCG Crossover are the most recent investors. CG Oncology has a post-money valuation in the range of $100M to $500M as of …

crunchbase.com

$47
OFF

CG Oncology Closes $47 Million Series D Financing - BioSpace

20 hours ago

Dec 10, 2020 · IRVINE, Calif.--(BUSINESS WIRE)-- CG Oncology, Inc., a clinical-stage biopharmaceutical company focused on the development of novel oncolytic immunotherapies, …

biospace.com

$47
OFF

CG Oncology Closes $47 Million Series D Financing | CG Oncology

20 hours ago

IRVINE, Calif., December 10, 2020 – CG Oncology, Inc., a clinical-stage biopharmaceutical company focused on the development of novel oncolytic immunotherapies, today announced …

cgoncology.com

$15.53
OFF

CG Oncology Company Profile 2024: Stock Performance

20 hours ago

CG Oncology’s EPS for 12 months was -$15.53. Data Transparency. Meet our data hygiene team. Discover how our experts ensure you’re getting the most accurate financial data in the …

pitchbook.com

$47
OFF

CG Oncology Closes $47 Million Series D Financing

20 hours ago

On December 10, 2020 CG Oncology, Inc., a clinical-stage biopharmaceutical company focused on the development of novel oncolytic immunotherapies, reported the closing of a $47 million …

1stoncology.com

$105
OFF

CG Oncology Announces $105 Million Oversubscribed Crossover …

20 hours ago

Aug 2, 2023 · – Co-led by new investors Foresite Capital and TCGX – – Proceeds to advance late-stage clinical programs in bladder cancer towards FDA approval – August 2, 2023, 8:00 …

cgoncology.com

$350
OFF

Series E - CG Oncology - 2022-11-15 - Crunchbase

20 hours ago

Nov 15, 2022 · Crunchbase News — The 10 Biggest Rounds Of November: Aspen Powers Up With $350M; DispatchHealth Raises Big For In-Home Care News • Nov 17, 2022 36 krypton …

crunchbase.com

$10000000
OFF

Series B - CG Oncology - 2015-08-05 - Crunchbase

20 hours ago

Aug 5, 2015 · CG Oncology raised $10000000 on 2015-08-05 in Series B. WI Harper Group WI Harper Group is a venture capital firm that focuses on early and expansion investments in …

crunchbase.com

FAQs about Series D - CG Oncology - 2020-12-10 - Crunchbase Coupon?

How many investors does CG oncology have?

CG Oncology has 20 investors including Foresite Capital and TCG Crossover. How much funding has CG Oncology raised to date? CG Oncology has raised . When was the last funding round for CG Oncology? CG Oncology closed its last funding round on Aug 2, 2023 from a Series F round. ...

Who is CG oncology?

View contacts for CG Oncology to access new leads and connect with decision-makers. CG Oncology formerly known as Cold Genesys is a privately held, clinical-stage biopharmaceutical company that focuses on the research, acquisition, and development of novel immunotherapies. ...

When did CG oncology close?

CG Oncology closed its last funding round on Aug 2, 2023 from a Series F round. Who are CG Oncology 's competitors? Alternatives and possible competitors to CG Oncology may include Prothena , Galecto , and Aimmune Therapeutics. ...

Did CG oncology raise money?

CG Oncology has raised . When was the last funding round for CG Oncology? CG Oncology closed its last funding round on Aug 2, 2023 from a Series F round. Who are CG Oncology 's competitors? ...

What are alternatives to CG oncology?

Alternatives and possible competitors to CG Oncology may include Prothena , Galecto , and Aimmune Therapeutics. CG Oncology is a clinical-stage biopharmaceutical company focused on the development of oncolytic immunotherapies to combat cancer. ...

Where is CG oncology located?

CG Oncology is located in Irvine, California, United States. Who invested in CG Oncology? CG Oncology has 20 investors including Foresite Capital and TCG Crossover. How much funding has CG Oncology raised to date? ...